tradingkey.logo
tradingkey.logo
Search

Inmode Ltd

INMD
Add to Watchlist
15.140USD
+0.045+0.30%
Close 07-31 16:00ETQuotes delayed by 15 min
870.26MMarket Cap
11.06P/E TTM
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+0.30%

5 Days

-0.20%

1 Month

+2.30%

6 Months

-8.90%

Year to Date

+3.06%

1 Year

+10.19%

Key Figures
15.090Open
15.190High
472.63KVolume
11.06P/E TTM
10.93P/E Dynamic
--Dividend TTM
0.75%Turnover Ratio
15.095Prev. Close
14.995Low
5.24MTurnover
5.29P/E Static
1.40P/B
0.00%Div Yield TTM
11.98%ROA
16.74052wk High
0.72Volume Ratio
181.28MNet Profit
63.36MShares
1.3694EPS TTM
1.95Beta
13.62%ROE
12.72052wk Low
1.29%Amplitude
75.05%Gross Margin
870.26MMarket Cap
2.09Reward/Risk
1.62%Risk Rate

TradingKey Stock Score of Inmode Ltd

Currency: USD Updated: 2026-07-31

Key Insights

Inmode Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 80 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 15.33.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inmode Ltd's Score

Industry at a Glance

Industry Ranking
80 / 199
Overall Ranking
166 / 4281
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Inmode Ltd Highlights

StrengthsRisks
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Overvalued
The company’s latest PE is 11.06, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 33.96M shares, decreasing 35.22% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.

Analyst Rating

Based on 6 analysts
Hold
Current Rating
15.333
Target Price
+1.28%
Upside Space

Inmode Ltd News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 6 analysts
Hold
Current Rating
15.333
Target Price
+1.28%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Inmode Ltd
INMD
6
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18

Indicators

Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.121
Neutral
RSI(14)
54.977
Neutral
STOCH(KDJ)(9,3,3)
31.803
Neutral
ATR(14)
0.301
High Vlolatility
CCI(14)
-69.961
Neutral
Williams %R
65.031
Sell
TRIX(12,20)
0.293
Sell
StochRSI(14)
9.759
Oversold
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
15.247
Sell
MA10
15.241
Sell
MA20
15.136
Buy
MA50
14.371
Buy
MA100
14.132
Buy
MA200
14.357
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Inmode Ltd Info

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Ticker SymbolINMD
CompanyInmode Ltd
CEOMizrahy (Moshe)
Websitehttps://inmodemd.com/

Shareholders

Shareholders
Shareholders
Proportion
Mizrahy (Moshe)
6.79%
Kreindel (Michael)
4.92%
DOMA Perpetual Capital Management, LLC
4.48%
Acadian Asset Management LLC
4.10%
Renaissance Technologies LLC
3.85%
Other
75.88%

FAQs

What is the current price of Inmode Ltd (INMD)?

The current price of Inmode Ltd (INMD) is 15.14.

What is the symbol of Inmode Ltd?

The ticker symbol of Inmode Ltd is INMD.

What is the 52-week high of Inmode Ltd?

The 52-week high of Inmode Ltd is 16.74.

What is the 52-week low of Inmode Ltd?

The 52-week low of Inmode Ltd is 12.72.

What is the market capitalization of Inmode Ltd?

The market capitalization of Inmode Ltd is 870.26M.

Is Inmode Ltd (INMD) currently rated as Buy, Hold, or Sell?

According to analysts, Inmode Ltd (INMD) has an overall rating of signal_hold, with a price target of 15.33.

What is the Earnings Per Share (EPS TTM) of Inmode Ltd (INMD)?

The Earnings Per Share (EPS TTM) of Inmode Ltd (INMD) is 1.45.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.